Prorenata Biotech is committed to accelerating the development and transition of gene-based therapeutics and vaccines to clinics. We are experts in CRISPR, Lipid Nanoparticles, and Genetic Medicine. Our mission is to lower the barrier for researchers to access novel approaches for moving their discoveries forward to benefit people struggling with health conditions that are yet to be addressed.